Erratum: Human ISL1+ Ventricular Progenitors Self-Assemble into an In Vivo Functional Heart Patch and Preserve Cardiac Function Post Infarction (Molecular Therapy (2018) 26(7) (1644–1659), (S1525001618300650), (10.1016/j.ymthe.2018.02.012));Human ISL1+ Ventricular Progenitors Self-Assemble into an In Vivo Functional Heart Patch and Preserve Cardiac Function Post Infarction

Molecular Therapy

Volumn 26, Issue 7, 2018, Pages 1644-1659

  Foo, Kylie S ^a   Lehtinen, Miia L ^a   Leung, Chuen Yan ^a   Lian, Xiaojun ^a,e   Xu, Jiejia ^a   Keung, Wendy ^b,c   Geng, Lin ^b,c   Kolstad, Terje R S ^d   Thams, Sebastian ^a   Wong, Andy On tik ^b   Wong, Nicodemus ^b,c   Bylund, Kristine ^a   Zhou, Chikai ^a   He, Xiaobing ^a   Jin, Shao Bo ^a   Clarke, Jonathan ^a   Lendahl, Urban ^a   Li, Ronald A ^a,b,c   Louch, William E ^d   Chien, Kenneth R ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c THE UNIVERSITY OF HONG KONG   (Hong Kong)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e The Pennsylvania State University   (United States)

Author keywords

cardiac regeneration; differentiation; human; myocardial infarction; stem cell; ventricular progenitor

Indexed keywords

CELL SURFACE MARKER; LAMININ; SMOOTH MUSCLE ACTIN; VASCULAR ENDOTHELIAL CADHERIN; INSULIN GENE ENHANCER BINDING PROTEIN ISL-1; LIM HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR;

ACTION POTENTIAL; ARTICLE; CARDIAC MUSCLE CELL; CELL DIFFERENTIATION; CELL SELECTION; CONTROLLED STUDY; DESMOSOME; DRESSLER SYNDROME; EXTRACELLULAR MATRIX; FLUORESCENCE ACTIVATED CELL SORTING; GEL; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART TISSUE; HEART VENTRICLE WALL; HUMAN; HUMAN CELL; IN VIVO STUDY; INDUCED PLURIPOTENT STEM CELL; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; STEM CELL; TRANSVERSE TUBULAR SYSTEM; VASCULAR SMOOTH MUSCLE; WNT SIGNALING; ANIMAL; CARDIAC MUSCLE; CELL CULTURE; CELL SEPARATION; HEART VENTRICLE; MALE; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; HEART VENTRICLES; HUMANS; LIM-HOMEODOMAIN PROTEINS; MALE; MICE; MICE, INBRED NOD; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; TRANSCRIPTION FACTORS;

EID: 85045002151     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1016/j.ymthe.2020.11.015     Document Type: Erratum

References (58)

1. Bui, A.L., Horwich, T.B., Fonarow, G.C., Epidemiology and risk profile of heart failure. Nat. Rev. Cardiol. 8 (2011), 30–41.
2. Lin, Z., Pu, W.T., Strategies for cardiac regeneration and repair. Sci. Transl. Med., 6, 2014, 239rv1.
3. Bergmann, O., Bhardwaj, R.D., Bernard, S., Zdunek, S., Barnabé-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B.A., Druid, H., et al. Evidence for cardiomyocyte renewal in humans. Science 324 (2009), 98–102.
4. Bergmann, O., Zdunek, S., Felker, A., Salehpour, M., Alkass, K., Bernard, S., Sjostrom, S.L., Szewczykowska, M., Jackowska, T., Dos Remedios, C., et al. Dynamics of cell generation and turnover in the human heart. Cell 161 (2015), 1566–1575.
5. Senyo, S.E., Steinhauser, M.L., Pizzimenti, C.L., Yang, V.K., Cai, L., Wang, M., Wu, T.D., Guerquin-Kern, J.L., Lechene, C.P., Lee, R.T., Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493 (2013), 433–436.
6. Khan, M., Xu, Y., Hua, S., Johnson, J., Belevych, A., Janssen, P.M., Gyorke, S., Guan, J., Angelos, M.G., Evaluation of changes in morphology and function of human induced pluripotent stem cell derived cardiomyocytes (HiPSC-CMs) cultured on an aligned-nanofiber cardiac patch. PLoS One, 10, 2015, e0126338.
7. Wu, S.M., Fujiwara, Y., Cibulsky, S.M., Clapham, D.E., Lien, C.L., Schultheiss, T.M., Orkin, S.H., Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127 (2006), 1137–1150.
8. Moretti, A., Caron, L., Nakano, A., Lam, J.T., Bernshausen, A., Chen, Y., Qyang, Y., Bu, L., Sasaki, M., Martin-Puig, S., et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127 (2006), 1151–1165.
9. He, J.Q., Ma, Y., Lee, Y., Thomson, J.A., Kamp, T.J., Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ. Res. 93 (2003), 32–39.
10. Mummery, C., Ward-van Oostwaard, D., Doevendans, P., Spijker, R., van den Brink, S., Hassink, R., van der Heyden, M., Opthof, T., Pera, M., de la Riviere, A.B., et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107 (2003), 2733–2740.
11. Tang, C., Lee, A.S., Volkmer, J.P., Sahoo, D., Nag, D., Mosley, A.R., Inlay, M.A., Ardehali, R., Chavez, S.L., Pera, R.R., et al. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat. Biotechnol. 29 (2011), 829–834.
12. Lee, A.S., Tang, C., Rao, M.S., Weissman, I.L., Wu, J.C., Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat. Med. 19 (2013), 998–1004.
13. Caspi, O., Huber, I., Kehat, I., Habib, M., Arbel, G., Gepstein, A., Yankelson, L., Aronson, D., Beyar, R., Gepstein, L., Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol. 50 (2007), 1884–1893.
14. Di Giorgio, F.P., Boulting, G.L., Bobrowicz, S., Eggan, K.C., Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 3 (2008), 637–648.
15. Pagliuca, F.W., Millman, J.R., Gürtler, M., Segel, M., Van Dervort, A., Ryu, J.H., Peterson, Q.P., Greiner, D., Melton, D.A., Generation of functional human pancreatic β cells in vitro. Cell 159 (2014), 428–439.
16. Spence, J.R., Mayhew, C.N., Rankin, S.A., Kuhar, M.F., Vallance, J.E., Tolle, K., Hoskins, E.E., Kalinichenko, V.V., Wells, S.I., Zorn, A.M., et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470 (2011), 105–109.
17. Lian, X., Hsiao, C., Wilson, G., Zhu, K., Hazeltine, L.B., Azarin, S.M., Raval, K.K., Zhang, J., Kamp, T.J., Palecek, S.P., Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. USA 109 (2012), E1848–E1857.
18. Qyang, Y., Martin-Puig, S., Chiravuri, M., Chen, S., Xu, H., Bu, L., Jiang, X., Lin, L., Granger, A., Moretti, A., et al. The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/β-catenin pathway. Cell Stem Cell 1 (2007), 165–179.
19. Buikema, J.W., Mady, A.S., Mittal, N.V., Atmanli, A., Caron, L., Doevendans, P.A., Sluijter, J.P., Domian, I.J., Wnt/β-catenin signaling directs the regional expansion of first and second heart field-derived ventricular cardiomyocytes. Development 140 (2013), 4165–4176.
20. Pennica, D., Shaw, K.J., Swanson, T.A., Moore, M.W., Shelton, D.L., Zioncheck, K.A., Rosenthal, A., Taga, T., Paoni, N.F., Wood, W.I., Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J. Biol. Chem. 270 (1995), 10915–10922.
21. Wollert, K.C., Chien, K.R., Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development. J. Mol. Med. (Berl.) 75 (1997), 492–501.
22. Yang, L., Soonpaa, M.H., Adler, E.D., Roepke, T.K., Kattman, S.J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G.W., Linden, R.M., et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453 (2008), 524–528.
23. Bu, L., Jiang, X., Martin-Puig, S., Caron, L., Zhu, S., Shao, Y., Roberts, D.J., Huang, P.L., Domian, I.J., Chien, K.R., Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 460 (2009), 113–117.
24. Domian, I.J., Chiravuri, M., van der Meer, P., Feinberg, A.W., Shi, X., Shao, Y., Wu, S.M., Parker, K.K., Chien, K.R., Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science 326 (2009), 426–429.
25. O'Hara, T., Virág, L., Varró A., Rudy, Y., Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation. PLoS Comput. Biol., 7, 2011, e1002061.
26. Franz, M.R., Bargheer, K., Rafflenbeul, W., Haverich, A., Lichtlen, P.R., Monophasic action potential mapping in human subjects with normal electrocardiograms: direct evidence for the genesis of the T wave. Circulation 75 (1987), 379–386.
27. Burridge, P.W., Matsa, E., Shukla, P., Lin, Z.C., Churko, J.M., Ebert, A.D., Lan, F., Diecke, S., Huber, B., Mordwinkin, N.M., et al. Chemically defined generation of human cardiomyocytes. Nat. Methods 11 (2014), 855–860.
28. Chen, G., Li, S., Karakikes, I., Ren, L., Chow, M.Z., Chopra, A., Keung, W., Yan, B., Chan, C.W., Costa, K.D., et al. Phospholamban as a crucial determinant of the inotropic response of human pluripotent stem cell-derived ventricular cardiomyocytes and engineered 3-dimensional tissue constructs. Circ Arrhythm Electrophysiol 8 (2015), 193–202.
29. Liu, J., Fu, J.D., Siu, C.W., Li, R.A., Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Stem Cells 25 (2007), 3038–3044.
30. Louch, W.E., Koivumäki, J.T., Tavi, P., Calcium signalling in developing cardiomyocytes: implications for model systems and disease. J. Physiol. 593 (2015), 1047–1063.
31. Weng, Z., Kong, C.W., Ren, L., Karakikes, I., Geng, L., He, J., Chow, M.Z., Mok, C.F., Chan, H.Y.S., Webb, S.E., et al. A simple, cost-effective but highly efficient system for deriving ventricular cardiomyocytes from human pluripotent stem cells. Stem Cells Dev. 23 (2014), 1704–1716.
32. Ziman, A.P., Gómez-Viquez, N.L., Bloch, R.J., Lederer, W.J., Excitation-contraction coupling changes during postnatal cardiac development. J. Mol. Cell. Cardiol. 48 (2010), 379–386.
33. O'Brien, T.X., Lee, K.J., Chien, K.R., Positional specification of ventricular myosin light chain 2 expression in the primitive murine heart tube. Proc. Natl. Acad. Sci. USA 90 (1993), 5157–5161.
34. Forbes, S.J., Rosenthal, N., Preparing the ground for tissue regeneration: from mechanism to therapy. Nat. Med. 20 (2014), 857–869.
35. Webber, M.J., Khan, O.F., Sydlik, S.A., Tang, B.C., Langer, R., A perspective on the clinical translation of scaffolds for tissue engineering. Ann. Biomed. Eng. 43 (2015), 641–656.
36. Vunjak-Novakovic, G., Lui, K.O., Tandon, N., Chien, K.R., Bioengineering heart muscle: a paradigm for regenerative medicine. Annu. Rev. Biomed. Eng. 13 (2011), 245–267.
37. Wang, J., Hoshijima, M., Lam, J., Zhou, Z., Jokiel, A., Dalton, N.D., Hultenby, K., Ruiz-Lozano, P., Ross, J. Jr., Tryggvason, K., Chien, K.R., Cardiomyopathy associated with microcirculation dysfunction in laminin α4 chain-deficient mice. J. Biol. Chem. 281 (2006), 213–220.
38. Bassat, E., Mutlak, Y.E., Genzelinakh, A., Shadrin, I.Y., Baruch Umansky, K., Yifa, O., Kain, D., Rajchman, D., Leach, J., Riabov Bassat, D., et al. The extracellular matrix protein agrin promotes heart regeneration in mice. Nature 547 (2017), 179–184.
39. Zangi, L., Lui, K.O., von Gise, A., Ma, Q., Ebina, W., Ptaszek, L.M., Später, D., Xu, H., Tabebordbar, M., Gorbatov, R., et al. Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat. Biotechnol. 31 (2013), 898–907.
40. Gerbin, K.A., Yang, X., Murry, C.E., Coulombe, K.L.K., Enhanced electrical integration of engineered human myocardium via intramyocardial versus epicardial delivery in infarcted rat hearts. PLoS One, 10, 2015, e0131446.
41. Laflamme, M.A., Chen, K.Y., Naumova, A.V., Muskheli, V., Fugate, J.A., Dupras, S.K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25 (2007), 1015–1024.
42. Burchfield, J.S., Dimmeler, S., Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogenesis Tissue Repair, 1, 2008, 4.
43. Gnecchi, M., He, H., Liang, O.D., Melo, L.G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R.E., Ingwall, J.S., Dzau, V.J., Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11 (2005), 367–368.
44. Ginis, I., Luo, Y., Miura, T., Thies, S., Brandenberger, R., Gerecht-Nir, S., Amit, M., Hoke, A., Carpenter, M.K., Itskovitz-Eldor, J., Rao, M.S., Differences between human and mouse embryonic stem cells. Dev. Biol. 269 (2004), 360–380.
45. Williams, R.L., Hilton, D.J., Pease, S., Willson, T.A., Stewart, C.L., Gearing, D.P., Wagner, E.F., Metcalf, D., Nicola, N.A., Gough, N.M., Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336 (1988), 684–687.
46. Sartiani, L., Bettiol, E., Stillitano, F., Mugelli, A., Cerbai, E., Jaconi, M.E., Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells 25 (2007), 1136–1144.
47. Menasché P., Vanneaux, V., Hagège, A., Bel, A., Cholley, B., Cacciapuoti, I., Parouchev, A., Benhamouda, N., Tachdjian, G., Tosca, L., et al. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. Eur. Heart J. 36 (2015), 2011–2017.
48. Takeda, M., Kanki, Y., Masumoto, H., Funakoshi, S., Hatani, T., Fukushima, H., Izumi-Taguchi, A., Matsui, Y., Shimamura, T., Yoshida, Y., Yamashita, J.K., Identification of cardiomyocyte-fated progenitors from human-induced pluripotent stem cells marked with CD82. Cell Rep. 22 (2018), 546–556.
49. Lian, X., Zhang, J., Zhu, K., Kamp, T.J., Palecek, S.P., Insulin inhibits cardiac mesoderm, not mesendoderm, formation during cardiac differentiation of human pluripotent stem cells and modulation of canonical Wnt signaling can rescue this inhibition. Stem Cells 31 (2013), 447–457.
50. Lian, X., Zhang, J., Azarin, S.M., Zhu, K., Hazeltine, L.B., Bao, X., Hsiao, C., Kamp, T.J., Palecek, S.P., Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nat. Protoc. 8 (2013), 162–175.
51. eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat. Methods 8 (2011), 1037–1040.
52. D'Amour, K.A., Agulnick, A.D., Eliazer, S., Kelly, O.G., Kroon, E., Baetge, E.E., Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23 (2005), 1534–1541.
53. Fu, J.-D., Jiang, P., Rushing, S., Liu, J., Chiamvimonvat, N., Li, R.A., Na+/Ca2+ exchanger is a determinant of excitation-contraction coupling in human embryonic stem cell-derived ventricular cardiomyocytes. Stem Cells Dev. 19 (2010), 773–782.
54. Chow, M., Boheler, K.R., Li, R.A., Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives. Stem Cell Res. Ther., 4, 2013, 97.
55. Smith, S.M., Jenkinson, M., Woolrich, M.W., Beckmann, C.F., Behrens, T.E., Johansen-Berg, H., Bannister, P.R., De Luca, M., Drobnjak, I., Flitney, D.E., et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23:Suppl 1 (2004), S208–S219.
56. Loening, A.M., Gambhir, S.S., AMIDE: a free software tool for multimodality medical image analysis. Mol. Imaging 2 (2003), 131–137.
57. Heiberg, E., Sjögren, J., Ugander, M., Carlsson, M., Engblom, H., Arheden, H., Design and validation of Segment–freely available software for cardiovascular image analysis. BMC Med. Imaging, 10, 2010, 1.
58. Cerqueira, M.D., Weissman, N.J., Dilsizian, V., Jacobs, A.K., Kaul, S., Laskey, W.K., Pennell, D.J., Rumberger, J.A., Ryan, T., Verani, M.S., American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002), 539–542.